Search by Drug Name or NDC
NDC 58596-0003-20 Mucus Relief Xpect 20; 400 mg/1; mg/1 Details
Mucus Relief Xpect 20; 400 mg/1; mg/1
Mucus Relief Xpect is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Selgel M. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN.
MedlinePlus Drug Summary
Dextromethorphan is used to temporarily relieve cough caused by the common cold, the flu, or other conditions. Dextromethorphan will relieve a cough but will not treat the cause of the cough or speed recovery. Dextromethorphan is in a class of medications called antitussives. It works by decreasing activity in the part of the brain that causes coughing.
Related Packages: 58596-0003-20Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Dextromethorphan
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Related Packages: 58596-0003-20Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Guaifenesin
Product Information
| NDC | 58596-0003 |
|---|---|
| Product ID | 58596-003_eb0096fe-dcf6-2ac6-e053-2a95a90aa8a1 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Mucus Relief Xpect |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Guaifensin, Dextromethorphan |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 20; 400 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN |
| Labeler Name | Selgel M |
| Pharmaceutical Class | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Ant |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | M012 |
| Listing Certified Through | 2024-12-31 |
Package
Package Images
NDC 58596-0003-20 (58596000320)
| NDC Package Code | 58596-003-20 |
|---|---|
| Billing NDC | 58596000320 |
| Package | 2 BLISTER PACK in 1 CARTON (58596-003-20) / 10 TABLET in 1 BLISTER PACK |
| Marketing Start Date | 2021-05-19 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL c2c82f4e-5e34-dd3e-e053-2a95a90a0877 Details
Uses
Warnings
Do not use
■ if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug.If you do not know if your prescription drug contains a MAOI, ask a doctor or pharmacist before taking this product.
Ask a doctor before use if you have
■ cough accompanied by excessive phlegm (mucus) ■ persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis or emphysema.
Directions
Other information
Inactive Ingredients
INGREDIENTS AND APPEARANCE
| MUCUS RELIEF XPECT
guaifensin, dextromethorphan tablet |
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
 |
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Labeler - Selgel México, S.A. de C.V. (812296782) |